Cargando…
Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages
BACKGROUND: Despite recent successes at controlling malaria, progress has stalled with an estimated 219 million cases and 435,000 deaths in 2017 alone. Combined with emerging resistance to front line antimalarial therapies in Southeast Asia, there is an urgent need for new treatment options and nove...
Autores principales: | Delves, Michael, Lafuente-Monasterio, M. Jose, Upton, Leanna, Ruecker, Andrea, Leroy, Didier, Gamo, Francisco-Javier, Sinden, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753678/ https://www.ncbi.nlm.nih.gov/pubmed/31572339 http://dx.doi.org/10.3389/fmicb.2019.02134 |
Ejemplares similares
-
Targeting the parasite in the mosquito: rationale and practicality
por: Sinden, Robert E, et al.
Publicado: (2012) -
Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts
por: Churcher, Thomas S., et al.
Publicado: (2017) -
A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies
por: Delves, Michael J, et al.
Publicado: (2010) -
Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen
por: Miguel-Blanco, Celia, et al.
Publicado: (2017) -
Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020)